Literature DB >> 23250339

Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells.

László Szabó1, Norbert Szentandrássy, Kornél Kistamás, Bence Hegyi, Ferenc Ruzsnavszky, Krisztina Váczi, Balázs Horváth, János Magyar, Tamás Bányász, Balázs Pál, Péter P Nánási.   

Abstract

Tacrolimus is a commonly used immunosuppressive agent which causes cardiovascular complications, e.g., hypertension and hypertrophic cardiomyopathy. In spite of it, there is little information on the cellular cardiac effects of the immunosuppressive agent tacrolimus in larger mammals. In the present study, therefore, the concentration-dependent effects of tacrolimus on action potential morphology and the underlying ion currents were studied in canine ventricular cardiomyocytes. Standard microelectrode, conventional whole cell patch clamp, and action potential voltage clamp techniques were applied in myocytes enzymatically dispersed from canine ventricular myocardium. Tacrolimus (3-30 μM) caused a concentration-dependent reduction of maximum velocity of depolarization and repolarization, action potential amplitude, phase-1 repolarization, action potential duration, and plateau potential, while no significant change in the resting membrane potential was observed. Conventional voltage clamp experiments revealed that tacrolimus concentrations ≥3 μM blocked a variety of ion currents, including I(Ca), I(to), I(K1), I(Kr), and I(Ks). Similar results were obtained under action potential voltage clamp conditions. These effects of tacrolimus developed rapidly and were fully reversible upon washout. The blockade of inward currents with the concomitant shortening of action potential duration in canine myocytes is the opposite of those observed previously with tacrolimus in small rodents. It is concluded that although tacrolimus blocks several ion channels at higher concentrations, there is no risk of direct interaction with cardiac ion channels when applying tacrolimus in therapeutic concentrations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23250339     DOI: 10.1007/s00210-012-0823-2

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium.

Authors:  Norbert Szentadrassy; Tamas Banyasz; Tamas Biro; Gergely Szabo; Balazs I Toth; Janos Magyar; Jozsef Lazar; Andras Varro; Laszlo Kovacs; Peter P Nanasi
Journal:  Cardiovasc Res       Date:  2005-03-01       Impact factor: 10.787

2.  Asymmetrical distribution of ion channels in canine and human left-ventricular wall: epicardium versus midmyocardium.

Authors:  Gergely Szabó; Norbert Szentandrássy; Tamás Bíró; Balázs I Tóth; Gabriella Czifra; János Magyar; Tamás Bányász; András Varró; László Kovács; Péter P Nánási
Journal:  Pflugers Arch       Date:  2005-06-11       Impact factor: 3.657

3.  Is ryanodine receptor phosphorylation key to the fight or flight response and heart failure?

Authors:  Thomas Eschenhagen
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

4.  Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of I(Ca,L).

Authors:  Torsten Christ; Erich Wettwer; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-06-16       Impact factor: 3.000

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

Review 6.  Immunophilins and cardiovascular complications.

Authors:  E Calderón-Sánchez; M Rodriguez-Moyano; T Smani
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

7.  A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.

Authors:  Kinan Rifai; Gabriele I Kirchner; Matthias J Bahr; Tobias Cantz; Jens Rosenau; Björn Nashan; Jürgen L Klempnauer; Michael P Manns; Christian P Strassburg
Journal:  Liver Transpl       Date:  2006-03       Impact factor: 5.799

8.  Different effects of endothelin-1 on calcium and potassium currents in canine ventricular cells.

Authors:  T Bányász; J Magyar; A Körtvély; G Szigeti; P Szigligeti; Z Papp; A Mohácsi; L Kovács; P P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-04       Impact factor: 3.000

9.  Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes.

Authors:  János Magyar; Norbert Szentandrássy; Tamás Bányász; Valéria Kecskeméti; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-08-26       Impact factor: 3.000

10.  Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients.

Authors:  P Atkison; G Joubert; A Barron; D Grant; K Paradis; E Seidman; W Wall; H Rosenberg; J Howard; S Williams
Journal:  Lancet       Date:  1995-04-08       Impact factor: 79.321

View more
  4 in total

1.  Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes.

Authors:  Ferenc Ruzsnavszky; Bence Hegyi; Kornél Kistamás; Krisztina Váczi; Balázs Horváth; Norbert Szentandrássy; Tamás Bányász; Péter P Nánási; János Magyar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-02-25       Impact factor: 3.000

2.  Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.

Authors:  Balázs Horváth; Norbert Szentandrássy; Roland Veress; János Almássy; János Magyar; Tamás Bányász; Attila Tóth; Zoltán Papp; Péter P Nánási
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-22       Impact factor: 3.000

Review 3.  Calcium Handling Defects and Cardiac Arrhythmia Syndromes.

Authors:  Kornél Kistamás; Roland Veress; Balázs Horváth; Tamás Bányász; Péter P Nánási; David A Eisner
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

4.  Systemic Lupus Erythematosus Complicated with Hypertrophic Cardiomyopathy: A Case Report and Literature Review.

Authors:  Huihui Ma; Xin Cao; Jing Zhang; Yongmei Zhou; Rong Luo; Tao He; Jianhong Tao; Xiaoping Li
Journal:  Case Rep Cardiol       Date:  2021-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.